Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,724 | 633 | 98.7% |
| Consulting Fee | $150.00 | 1 | 1.0% |
| Education | $38.30 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,983 | 59 | $0 (2024) |
| Amgen Inc. | $1,450 | 40 | $0 (2024) |
| PFIZER INC. | $1,118 | 43 | $0 (2024) |
| ABBVIE INC. | $894.57 | 39 | $0 (2024) |
| Lilly USA, LLC | $760.32 | 40 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $752.05 | 42 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $629.02 | 26 | $0 (2024) |
| GlaxoSmithKline, LLC. | $584.26 | 17 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $529.25 | 28 | $0 (2024) |
| Astellas Pharma US Inc | $519.06 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,483 | 46 | Amgen Inc. ($270.20) |
| 2023 | $1,334 | 45 | ABBVIE INC. ($320.66) |
| 2022 | $1,176 | 48 | Novo Nordisk Inc ($469.36) |
| 2021 | $1,837 | 76 | Novo Nordisk Inc ($310.56) |
| 2020 | $1,669 | 87 | Amgen Inc. ($251.88) |
| 2019 | $1,178 | 57 | GlaxoSmithKline, LLC. ($244.01) |
| 2018 | $3,377 | 119 | Amgen Inc. ($503.31) |
| 2017 | $2,858 | 161 | PFIZER INC. ($244.56) |
All Payment Transactions
639 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: PAIN | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $29.27 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Gastroenterology | ||||||
| 11/07/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Bone Health | ||||||
| 10/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Obesity | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Respiratory | ||||||
| 09/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $85.75 | General |
| 09/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: PAIN | ||||||
| 08/21/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Diabetes Care | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.79 | General |
| 08/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Gastroenterology | ||||||
| 08/08/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: Diabetes | ||||||
| 07/25/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: PAIN | ||||||
| 07/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Respiratory | ||||||
| 07/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: Diabetes | ||||||
| 06/07/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $32.09 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 435 | 998 | $246,335 | $95,950 |
| 2022 | 6 | 406 | 1,037 | $195,644 | $104,548 |
| 2021 | 6 | 394 | 1,012 | $193,358 | $108,444 |
| 2020 | 7 | 454 | 1,120 | $209,603 | $110,114 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 189 | 628 | $175,208 | $65,527 | 37.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 114 | 238 | $46,782 | $17,114 | 36.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 70 | 70 | $11,900 | $8,836 | 74.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $8,292 | $2,727 | 32.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 25 | $3,425 | $1,600 | 46.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 14 | $728.00 | $146.51 | 20.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 186 | 693 | $142,758 | $75,283 | 52.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 107 | 230 | $33,182 | $17,758 | 53.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 57 | 57 | $9,690 | $7,409 | 76.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 27 | 27 | $7,938 | $3,101 | 39.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 12 | $1,140 | $802.90 | 70.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 18 | 18 | $936.00 | $193.75 | 20.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 192 | 719 | $148,114 | $82,127 | 55.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 85 | 163 | $23,472 | $12,579 | 53.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 71 | 71 | $12,322 | $9,433 | 76.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 16 | 16 | $4,560 | $2,117 | 46.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 20 | $1,900 | $1,212 | 63.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 14 | 23 | $2,990 | $976.58 | 32.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 202 | 739 | $152,234 | $77,925 | 51.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 96 | 185 | $26,640 | $14,728 | 55.3% |
| 99354 | Prolonged office or other outpatient service first hour | Office | 2020 | 75 | 101 | $15,288 | $10,012 | 65.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 23 | 23 | $6,762 | $3,002 | 44.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 29 | 35 | $3,325 | $2,003 | 60.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 12 | 12 | $2,104 | $1,376 | 65.4% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 17 | 25 | $3,250 | $1,068 | 32.9% |
About Dr. Steven Ma, MD
Dr. Steven Ma, MD is a Family Medicine healthcare provider based in Fredericksburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1609864669.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Ma, MD has received a total of $14,912 in payments from pharmaceutical and medical device companies, with $1,483 received in 2024. These payments were reported across 639 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($14,724).
As a Medicare-enrolled provider, Ma has provided services to 1,689 Medicare beneficiaries, totaling 4,167 services with total Medicare billing of $419,057. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Fredericksburg, VA
- Active Since 10/12/2005
- Last Updated 06/05/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1609864669
Products in Payments
- XIFAXAN (Drug) $689.33
- Repatha (Biological) $669.85
- UBRELVY (Drug) $562.57
- VRAYLAR (Drug) $529.06
- Saxenda (Drug) $526.74
- Vascepa (Drug) $500.50
- Livalo (Drug) $488.15
- Ozempic (Drug) $470.42
- FARXIGA (Drug) $462.56
- Aimovig (Biological) $421.11
- TRELEGY ELLIPTA (Drug) $414.19
- Morphabond ER (Drug) $372.98
- Wegovy (Drug) $358.04
- TROKENDI XR (Drug) $357.25
- CHANTIX (Drug) $312.63
- EMGALITY (Drug) $287.79
- MOUNJARO (Drug) $271.54
- Prolia (Biological) $212.68
- NURTEC ODT (Drug) $211.06
- Victoza (Drug) $198.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Fredericksburg
Dr. Dana Brown, M.d, M.D
Family Medicine — Payments: $23,280
Julie Floyd, M.d, M.D
Family Medicine — Payments: $22,869
Wilson Cook, M.d, M.D
Family Medicine — Payments: $19,339
Rafael Hernandez, M.d, M.D
Family Medicine — Payments: $19,174
Dr. Nelson Henry, M.d, M.D
Family Medicine — Payments: $14,770
Donna Gamache, M.d, M.D
Family Medicine — Payments: $11,509